Extracellular vesicles as potential biomarkers and therapeutic approaches in autoimmune diseases

[1]  C. Chim,et al.  The functional role of surface molecules on extracellular vesicles in cancer, autoimmune diseases, and coagulopathy , 2020, Journal of leukocyte biology.

[2]  Y. Zhang,et al.  Potential roles of extracellular vesicles in the pathophysiology, diagnosis, and treatment of autoimmune diseases , 2020, International journal of biological sciences.

[3]  M. Rickels,et al.  Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  F. Ferro,et al.  Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjögren's syndrome. , 2019, Clinical and experimental rheumatology.

[5]  M. Rojas,et al.  Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis , 2019, Arthritis Research & Therapy.

[6]  Gang Zhou,et al.  Circulating exosomes regulate T‐cell–mediated inflammatory response in oral lichen planus , 2018, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[7]  M. Rojas,et al.  Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus , 2018, Front. Immunol..

[8]  P. Merkel,et al.  Nomenclature of Cutaneous Vasculitis , 2018, Arthritis & rheumatology.

[9]  P. Robbins,et al.  Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes , 2017, Scientific Reports.

[10]  K. Zen,et al.  Distinct expression profile of HCMV encoded miRNAs in plasma from oral lichen planus patients , 2017, Journal of Translational Medicine.

[11]  L. Caminal-Montero,et al.  Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity. , 2017, International journal of cardiology.

[12]  B. Thiede,et al.  Identification of potential saliva and tear biomarkers in primary Sjögren’s syndrome, utilising the extraction of extracellular vesicles and proteomics analysis , 2017, Arthritis Research & Therapy.

[13]  M. Laffan,et al.  A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome , 2016, Scientific Reports.

[14]  A. Larsson,et al.  Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations , 2016, Scientific Reports.

[15]  P. Fortin,et al.  Distinct Subtypes of Microparticle-containing Immune Complexes Are Associated with Disease Activity, Damage, and Carotid Intima-media Thickness in Systemic Lupus Erythematosus , 2016, The Journal of Rheumatology.

[16]  Qianming Chen,et al.  MicroRNAs in oral lichen planus and potential miRNA-mRNA pathogenesis with essential cytokines: a review. , 2016, Oral surgery, oral medicine, oral pathology and oral radiology.

[17]  Y. Liu,et al.  Recent advances of exosomes in immune modulation and autoimmune diseases , 2016, Autoimmunity.

[18]  G. Espinosa,et al.  Procoagulant microparticles are increased in patients with Behçet’s disease but do not define a specific subset of clinical manifestations , 2016, Clinical Rheumatology.

[19]  S. Mathivanan,et al.  Focus on Extracellular Vesicles: Introducing the Next Small Big Thing , 2016, International journal of molecular sciences.

[20]  P. Blanco,et al.  Role of extracellular vesicles in autoimmune diseases. , 2016, Autoimmunity reviews.

[21]  Yasutomo Yajima,et al.  Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations , 2016, Journal of extracellular vesicles.

[22]  Nunzio Iraci,et al.  Acellular approaches for regenerative medicine: on the verge of clinical trials with extracellular membrane vesicles? , 2015, Stem Cell Research & Therapy.

[23]  A. Lerner,et al.  The World Incidence and Prevalence of Autoimmune Diseases is Increasing , 2015 .

[24]  J. Byun,et al.  Diagnostic profiling of salivary exosomal microRNAs in oral lichen planus patients. , 2015, Oral diseases.

[25]  J. Fransen,et al.  Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis , 2015, Arthritis & rheumatology.

[26]  R. González-Amaro,et al.  Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease , 2015, Clinical and experimental immunology.

[27]  A. Abbas,et al.  Mechanisms of human autoimmunity. , 2015, The Journal of clinical investigation.

[28]  R. Gerli,et al.  Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? , 2015, Rheumatology.

[29]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[30]  D. Conrad,et al.  Antigen Transfer from Exosomes to Dendritic Cells as an Explanation for the Immune Enhancement Seen by IgE Immune Complexes , 2014, PloS one.

[31]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[32]  S. Knudsen,et al.  Unique protein signature of circulating microparticles in systemic lupus erythematosus. , 2013, Arthritis and rheumatism.

[33]  S. Lim,et al.  Exosomes for drug delivery - a novel application for the mesenchymal stem cell. , 2013, Biotechnology advances.

[34]  C. Dubois,et al.  Revisited role of microparticles in arterial and venous thrombosis , 2013, Journal of thrombosis and haemostasis : JTH.

[35]  Ian N Bruce,et al.  Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus , 2013, Annals of the rheumatic diseases.

[36]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[37]  Melissa G. Piper,et al.  Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. , 2013, Blood.

[38]  D. Haskard,et al.  Differential diagnosis and management of Behçet syndrome , 2013, Nature Reviews Rheumatology.

[39]  C. Qualls,et al.  Circulating microparticles in neuropsychiatric systemic lupus erythematosus , 2013, International journal of rheumatic diseases.

[40]  B. Engelmann,et al.  Thrombosis as an intravascular effector of innate immunity , 2012, Nature Reviews Immunology.

[41]  K. Nylander,et al.  Increased levels of COX‐2 in oral lichen planus supports an autoimmune cause of the disease , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[42]  A. Molinari,et al.  Immune Surveillance Properties of Human NK Cell-Derived Exosomes , 2012, The Journal of Immunology.

[43]  Yongbo Huang,et al.  Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. , 2012, Thrombosis research.

[44]  A. Guimarães,et al.  Increased miRNA-146a and miRNA-155 expressions in oral lichen planus , 2012, Archives of Dermatological Research.

[45]  A. Alzolibani,et al.  Antibodies against 4-Hydroxy-2-nonenal Modified Epitopes Recognized Chromatin and Its Oxidized Forms: Role of Chromatin, Oxidized Forms of Chromatin and 4-Hydroxy-2-nonenal Modified Epitopes in the Etiopathogenesis of SLE , 2012, Disease markers.

[46]  J. Paramo,et al.  Synergistic Effect of Thrombin and CD40 Ligand on Endothelial Matrix Metalloproteinase-10 Expression and Microparticle Generation In Vitro and In Vivo , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[47]  L. Truedsson,et al.  Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. , 2012, Arthritis and rheumatism.

[48]  G. Valesini,et al.  Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[49]  M. Macey,et al.  Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. , 2011, Rheumatology.

[50]  C. Johnsen,et al.  Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[51]  Marc Monestier,et al.  Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. , 2011, Journal of autoimmunity.

[52]  G. Illei,et al.  MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. , 2011, Arthritis and rheumatism.

[53]  P. Youinou,et al.  Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies. , 2010, Rheumatology.

[54]  X. Mariette,et al.  Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity , 2009, Arthritis research & therapy.

[55]  J. Freyssinet,et al.  Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. , 2009, Atherosclerosis.

[56]  Nigel Mackman,et al.  Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. , 2008, The Journal of clinical investigation.

[57]  S. Eichinger,et al.  Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.

[58]  W. Grizzle,et al.  A Membrane Form of TNF-α Presented by Exosomes Delays T Cell Activation-Induced Cell Death1 , 2006, The Journal of Immunology.

[59]  C. Sáez,et al.  Circulating platelet-derived microparticles in systemic lupus erythematosus , 2005, Thrombosis and Haemostasis.

[60]  Nigel Mackman,et al.  Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. , 2004, Blood.

[61]  Gang Zhou,et al.  Differentially circulating exosomal microRNAs expression profiling in oral lichen planus. , 2018, American journal of translational research.

[62]  S. Katsiougiannis.  Extracellular Vesicles: Evolving Contributors in Autoimmunity. , 2015, Forum on immunopathological diseases and therapeutics.

[63]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[64]  G. Illei,et al.  Exosomes from human saliva as a source of microRNA biomarkers. , 2010, Oral diseases.

[65]  W. Grizzle,et al.  A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. , 2006, Journal of immunology.

[66]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..